12
Participants
Start Date
May 1, 2019
Primary Completion Date
February 28, 2020
Study Completion Date
March 28, 2021
PHACOEMULSIFICATION
"Standard phacoemulsification with intraocular lens implant will be perform within 60 days after allocation. If IOP target is not achieve, patients will be treated as in medical treatment group"
MEDICAL GLAUCOMA TREATMENT
The escalation of topical hypotensive medications will be carried out with the following sequence: 1. single topical medication; 2. double topical therapy; 3. triple topical therapy. Beginning, with the exception of individual contraindications, with prostaglandin analogs, followed by topical beta-blockers, carbonic anhydrase inhibitors and finally alpha-agonists.Target IOP will be used in both groups to inform the need of escalation of therapy; in patients with ocular hypertension the target IOP will be 21 mmHg. In patients with mild glaucoma target IOP will be 18 mmHg, and in patients with moderate glaucoma the target IOP will be 15 mmHg.
Sara Pose-Bazarra, Ferrol
Xerencia de Xestión Integrada de Ferrol
OTHER